New pill could help babies fight RSV faster
Disease control
Not yet recruiting
This study tests an experimental oral drug called zelicapavir in 150 children aged 1 month to 3 years who have respiratory syncytial virus (RSV). The drug aims to stop the virus from multiplying and speed up recovery. Half the children will get the drug, half a placebo, and resea…
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC